Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
44
Application of topical cream twice a day on the area affected by Atopic Dermatitis
Application of topical cream twice a day on the area affected by Atopic Dermatitis
Complife Italia S.r.l.
San Martino Siccomario, Italy
Change in severity of Atopic Dermatitis as assessed using the SCORing Atopic Dermatitis (SCORAD)
Time frame: 7, 14 and 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.